BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 4398216)

  • 1. Effect of 4-(2-hydroxy-3-isopropylaminopropoxy) acetanilide (AY 21,011) on the myocardial and coronary vascular responses to adrenergic stimulation.
    Lucchesi BR; Hodgeman RJ
    J Pharmacol Exp Ther; 1971 Jan; 176(1):200-11. PubMed ID: 4398216
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular pharmacology of two new beta-adrenergic receptor antagonists.
    Stanton HC; Kirchgessner T; Parmenter K
    J Pharmacol Exp Ther; 1965 Aug; 149(2):174-82. PubMed ID: 4378559
    [No Abstract]   [Full Text] [Related]  

  • 3. Localization of beta-receptors in the circulatory tract.
    Charbon GA; Reneman RS
    Pflugers Arch; 1970; 314(2):168-9. PubMed ID: 4391471
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of some sympathomimetic amines on the coronary resistance in the dog heart in situ during heart beat and asystole].
    Bassenge E; Doutheil U
    Arzneimittelforschung; 1970 Mar; 20(3):343-7. PubMed ID: 4392592
    [No Abstract]   [Full Text] [Related]  

  • 6. Blockade of cardiac effects of isoproterenol by 4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide (ICI 50,172).
    Somani P; Laddu AR
    J Pharmacol Exp Ther; 1969 Nov; 170(1):72-8. PubMed ID: 4390814
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of the cardioselective beta-receptor blocker (ICI 50172) on hemodynamics and oxygen consumption of the left ventricle in the dog (whole animal)].
    Bussmann WD; Krayenbühl HP
    Helv Physiol Pharmacol Acta; 1968; 26(2):CR 199+. PubMed ID: 5723448
    [No Abstract]   [Full Text] [Related]  

  • 8. Haemodynamic and coronary vascular responses after beta-adrenoceptor blockade in the anaesthetised dog: a comparison of tolamolol with practolol and propranolol.
    Adam KR; Boyles SM
    Eur J Pharmacol; 1974 Apr; 26(1):96-107. PubMed ID: 4151643
    [No Abstract]   [Full Text] [Related]  

  • 9. Direct and beta-adrenoreceptor blocking effects of 4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB-46) on myocardial hemodynamics.
    Laddu AR; Somani P
    Arch Int Pharmacodyn Ther; 1972 Mar; 196(1):5-15. PubMed ID: 4400602
    [No Abstract]   [Full Text] [Related]  

  • 10. Responses of coronary vessels to adrenergic stimuli.
    McRaven DR; Mark AL; Abboud FM; Mayer HE
    J Clin Invest; 1971 Apr; 50(4):773-8. PubMed ID: 4396052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in direct effects of adrenergic stimuli on coronary, cutaneous, and muscular vessels.
    Mark AL; Abboud FM; Schmid PG; Heistad DD; Mayer HE
    J Clin Invest; 1972 Feb; 51(2):279-87. PubMed ID: 4400290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenergic blocking properties of MJ 1999 and butoxamine on cardiac and vascular beta-receptors.
    Wilkenfeld BE; Levy B
    Arch Int Pharmacodyn Ther; 1968 Nov; 176(1):218-32. PubMed ID: 5709786
    [No Abstract]   [Full Text] [Related]  

  • 13. Coronary and myocardial effects of dopamine in the conscious dog: parasympatholytic augmentation of pressor and inotropic actions.
    Vatner SF; Millard RW; Higgins CB
    J Pharmacol Exp Ther; 1973 Nov; 187(2):280-95. PubMed ID: 4147854
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole A/Giudicelli JF, Schmitt H, Boissier JR: Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB 46), a new potent beta adrenergic blocking drug.
    Giudicelli JF; Schmitt H; Boissier JR
    J Pharmacol Exp Ther; 1969 Jul; 168(1):116-26. PubMed ID: 5792677
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulatory effects of oxprenolol, a new beta-adrenergic blocking agent.
    Reale A; Motolese M; Imhof P
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):288-93. PubMed ID: 4394124
    [No Abstract]   [Full Text] [Related]  

  • 16. Alpha and beta adrenergic receptors in the coronary vascular bed.
    Malindzak GS; Van Dyke AH; Green HD; Meredith JH
    Arch Int Pharmacodyn Ther; 1972 May; 197(1):112-22. PubMed ID: 4402326
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analysis of cardiac beta-receptors. Studies by means of dose-effect-curves of isoprenaline, propranolol and KL 255].
    Holtermann W; Lochner W
    Arzneimittelforschung; 1970 Jan; 20(1):8-12. PubMed ID: 4392501
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative study of the beta adrenergic blocking activities of propranolol and inpea.
    Hahn RA; Pendleton RG; Wardell JR
    J Pharmacol Exp Ther; 1968 May; 161(1):111-21. PubMed ID: 5648488
    [No Abstract]   [Full Text] [Related]  

  • 19. [Coronary flow and and cardiac output of waking dogs during physical exertion under beta-receptor blockade].
    Kucharczyk M; Holtz J; Stoian D; Bassenge E
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):384-5. PubMed ID: 4397504
    [No Abstract]   [Full Text] [Related]  

  • 20. Sympathetic vasodilatation, kallikrein release and adrenergic receptors in the cat submandibular salivary gland.
    Gautvik K; Kriz M; Lund-Larsen K; Waaler BA
    Acta Physiol Scand; 1974 Feb; 90(2):438-44. PubMed ID: 4823016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.